Uncaging Stent Patent US12599490B2 - Elixir Medical

The USPTO granted Patent US12599490B2 to Elixir Medical Corporation for an uncaging stent or luminal prosthesis. The invention comprises circumferential structural elements providing high strength post-deployment with the ability to uncage or allow scaffold and luminal expansion thereafter. The circumferential scaffold is formed from non-degradable material modified to expand and uncage after deployment.

For Elixir Medical Corporation, this patent grant establishes enforceable intellectual property rights providing a 20-year exclusivity period from the March 3, 2023 filing date. Competitors developing similar uncaging stent technologies must either design around the patent claims or seek licensing. Healthcare providers and patients may eventually benefit from access to this stent technology pending regulatory approvals for clinical use.